Virus elimination and inactivation continue to emerge as an important factor in overall bioprocess safety. As bioprocesses, products, and unit operations flourish, viral clearance will become more customized to industrial and individual situations. At the same time, the global viral clearance market will keep extending its purview. Viral clearance is also called viral safety. For example, in case of inactivation of reagents such as monoclonal antibodies and recombinant proteins, companies, CROs, and diagnostic testing labs need to evaluate the removal of specific viral strains or viral copy number in samples.
Viral clearance can be performed by numerous methods depending on product type, technique for production, and whether it is a medical device or not. Examples of the techniques used in viral clearance are qRT-PCR, PCR, real time PCR, ELISA (EIA), western blot, and transmission EM. Viral clearance is vital for final confirmation about the acceptable level of safety which can be taken in for a final product. The success ratio of viral clearance depends on the selection of suitable methods that make sure the removal or demolition of any viruses without disturbing the target protein. A number of factors must be considered when making this choice: the regulatory requirements, characteristics of the target protein, the mechanism(s) of clearance method(s), and the impact of process parameters.
The major driver of the global viral clearance market is increasing demand in the pharmaceutical and biotechnological industries. Rise in the number of new drug launches in various segments and associated drug approval processes are also boosting market growth. The global viral clearance market has been segmented based on technique, end-user, application, and region. Based on technique, the viral clearance market has been divided into viral detection method, viral removal method, and viral inactivation method. The viral detection method segment is estimated to account for the largest share of the global viral clearance market.
In terms of application, the market has been segmented into blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. The vaccines and therapeutics segment is projected to hold the largest market share. Based on end-user, the viral clearance market has been segmented into pharmaceutical and biotechnology companies, contract research organizations, academics and research institutes, and others. The others segment constitutes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, and toxicology laboratories.
Geographically, the global viral clearance market has been divided into North America, Europe, Asia Pacific, and Rest of the World (Latin America, Middle East, and Africa). In terms of region, North America accounted for the largest share of the viral clearance market, followed by Europe, and Asia. North America and Europe are likely to witness high demand for viral clearance assays as a result of technological advancement, rise in number of new drug launches, and patent expiry of popular branded drugs. Other factors driving the market in these regions are rapidly aging population, growing incidence of associated disease, and increased obesity rates.
The market in Asia Pacific is expected to expand at the highest growth rate during the forecast period. The considerable growth of the market in the region is attributable to growing public and private initiatives to increase awareness related to health and safety of medicinal treatment and constant growth in health care expenditure. Presence of a large chronically ill population, increasing number of private sector hospitals, rising affluence, advancements in technology, and expansion to rural health care infrastructure are also likely to drive the market.
Major companies operating in the viral clearance market are Avance Biosciences, Inc., BSL Bioservice, Charles River Laboratories International, Inc., Clean Cells, Inc., Lonza Group, Merck Millipore - Sigma-Aldrich, Texcell, Inc., and Wuxi Pharmatech (Cayman), Inc., among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.